Find a Pharmacy
Vertice Login
Info banner
A significant part of the Healthesystems vision is to create a more integrated experience for our customers

Category: Workers Comp

505 posts found

PTSD Legislation Continues to Grow

More states cover PTSD without physical injuries for first responders, and 24 states allow PTSD patients to use medical marijuana.
Read More

New Developments in Migraine Medications

A new wave of drugs that suppress CGRP proteins to reduce migraines could be on the horizon.
Read More

FDA Proposes New Clinical Endpoints for Development of Opioid-Use Disorder Drugs

Drugs to treat opioid dependence could be approved under new clinical endpoints other than reducing opioid use.
Read More

Healthe Clinical Leaders in the News

Our Chief Medical Officer and VP of Clinical Services comment on matters such as the use of anticonvulsants to treat pain and opioid prescriptions for inpatients.
Read More

New Opioid in Development May Offer Reduced Risk Profile

Phase 2/3 clinical trial results for Korsuva demonstrate pain relief with fewer side effects.
Read More

Mark of the Millennial: Managed Care for a New Generation

Millennials are more diverse and more open to alternative therapies, medical marijuana, healthcare technology, and dialogue surrounding psychosocial concerns.
Read More

Support for Marijuana Continues to Grow Across the Nation

A flurry of recent developments continues to bring the medical marijuana debate front and center, including further legalization, a Senate bill, a drug approval, and more.
Read More

JAMA Study Questions the Effectiveness of Negative Pressure Wound Therapy

In a randomized clinical trial of 460 patients, researchers found the treatment to have similar impact on self-rated disability as standard wound dressing.
Read More

Healthesystems at WCIEC Orlando 2018

Visit Healthesystems in booth #914 to see how we explore the conference’s “Cosmic” theme, and for a chance to win a $250 gift card.
Read More

Drug Approvals Impacting Workers’ Comp

The FDA recently approved drugs to treat opioid dependence, migraines, and rheumatoid arthritis.
Read More

The Burden of Opioid-Related Mortality in the United States

Among many findings, JAMA reports that 20% of deaths among those aged 25-34 were opioid-related.
Read More

More States Pass Opioid Prescription Limits

Within the last month, laws have passed in Tennessee, Colorado, South Carolina, Oklahoma, and Hawaii.
Read More

IQVIA Reports on Global Oncology Trends

Global spending on cancer therapies now exceeds $133 billion.
Read More

Healthe Leaders Comment on Clinical Use of Marijuana & MDMA

Our Chief Medical Officer and VP of Clinical Services comment on the clinical use of ecstasy and marijuana.
Read More

FDA Encourages Drug Developers to Focus on Buprenorphine Depot Products

A newly released draft guidance encourages the development of more sustained-release buprenorphine products.
Read More
1 2 3 4 5 30 31 32 33 34
lockmap-markermagnifiercrossmenuarrow-rightcross-circle